Stavra A. Xanthakos

Stavra A. Xanthakos

Auto-generated profile, based on publicly available information

Stavra A. Xanthakos

Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
MVMiriam Vos
Miriam Vos
SAStephanie H. Abrams
Stephanie H. Abrams
SBSarah E. Barlow
Sarah E. Barlow
SCSonia Caprio
Sonia Caprio
SDStephen R. Daniels
Stephen R. Daniels
SXStavra A. Xanthakos
Stavra A. Xanthakos

26 August 2010 in Hepatology
Verified
Journal Article
Open access
PDF file
RKRohit Kohli
Rohit Kohli
MKMichelle Kirby
Michelle Kirby
SXStavra A. Xanthakos
Stavra A. Xanthakos
SSSamir Softic
Samir Softic
AFAriel E. Feldstein
Ariel E. Feldstein
RSRandy J. Seeley
Randy J. Seeley
Diets high in saturated fat and fructose have been implicated in the development of obesity and nonalcoholic steatohepatitis (NASH) in humans. We hypothesized that mice exposed to a similar diet would develop NASH with fibrosis associated with increased hepatic oxidative stress that would be further reflected by increased plasma levels of the respiratory chain component, oxidized coenzyme Q9 (oxCoQ9). Adult male C57Bl/6 mice were randomly assigned to chow, high-fat (HF), or high-fat high-carbohydrate (HFHC) diets for 16 weeks. The chow and HF mice had free access to pure water, whereas the HFHC group received water with 55% fructose and 45% sucrose (wt/vol). The HFHC and HF groups had increased body weight, body fat mass, fasting glucose, and were insulin-resistant compared with chow mice. HF and HFHC consumed similar calories. Hepatic triglyceride content, plasma alanine aminotransferase, and liver weight were significantly increased in HF and HFHC mice compared with chow mice. Plasma cholesterol ( P < 0.001), histological hepatic fibrosis, liver hydroxyproline content ( P = 0.006), collagen 1 messenger RNA ( P = 0.003), CD11b-F4/80+Gr1+ monocytes ( P < 0.0001), transforming growth factor β1 mRNA ( P = 0.04), and α-smooth muscle actin messenger RNA ( P = 0.001) levels were significantly increased in HFHC mice. Hepatic oxidative stress, as indicated by liver superoxide expression ( P = 0.002), 4-hydroxynonenal, and plasma oxCoQ9 ( P < 0.001) levels, was highest in HFHC mice. Conclusion: These findings demonstrate that nongenetically modified mice maintained on an HFHC diet in addition to developing obesity have increased hepatic ROS and a NASH-like phenotype with significant fibrosis. Plasma oxCoQ9 correlated with fibrosis progression. The mechanism of fibrosis may involve fructose inducing increased ROS associated with CD11b+F4/80+Gr1+ hepatic macrophage aggregation, resulting in transforming growth factor β1–signaled collagen deposition and histologically visible hepatic fibrosis.

1 October 2009 in Pediatric Clinics of North America
Verified
Journal Article
Closed access
SXStavra A. Xanthakos
Stavra A. Xanthakos

1 September 2015 in Gastroenterology
Verified
Journal Article
Open access
PDF file
SXStavra A. Xanthakos
Stavra A. Xanthakos
TJTodd M. Jenkins
Todd M. Jenkins
DKDavid E. Kleiner
David E. Kleiner
TBTawny W. Boyce
Tawny W. Boyce
RMReena Mourya
Reena Mourya
TIThomas H. Inge
Thomas H. Inge
Background & Aims Little is known about the prevalence of nonalcoholic fatty liver disease (NAFLD) among severely obese adolescents or factors that determine its development. We investigated the prevalence of NAFLD in a multicenter cohort of adolescents undergoing bariatric surgery and the factors associated with it. Methods We enrolled 242 adolescents undergoing bariatric surgery between March 2007 and February 2012 at 5 tertiary care centers into a multicenter, prospective observational cohort study. Intraoperative core liver biopsies were collected from 165 subjects; 17 were excluded because of insufficient liver tissue or use of hepatotoxic medications, so 148 remained in the study (mean age, 16.8 ± 1.6 years; median body mass index = 52 kg/m2). Liver tissues were analyzed by histology using validated criteria. Hepatic gene expression was analyzed in 67 samples. Results NAFLD was present in 59% of this predominantly female (72%), white (68%), non-Hispanic (91%) cohort. Of subjects with NAFLD, 24% had borderline and 10% had definite nonalcoholic steatohepatitis (NASH). Mild fibrosis (stage 2 or lower) was observed in 18% of liver biopsies and stage 3 was observed in 0.7%, but cirrhosis was not detected. Dyslipidemia was present in 78% of subjects, hypertension in 44%, and diabetes in 14%. More severe NAFLD was associated with increasing levels of alanine aminotransferase, fasting glucose level, hypertension (each P < .01), and white blood cell count (P = .04). Only diabetes was associated with detection of fibrosis (odds ratio = 3.56; 95% confidence interval: 1.93−6.56). Microarray analysis associated presence of NASH with altered expression of genes that regulate macrophage chemotaxis, cholesterol absorption, and fatty acid binding. Conclusions More than half of adolescents undergoing bariatric surgery in this cohort had NAFLD, yet the prevalence of severe or fibrotic NASH was low. Increasing severity of NAFLD was associated with level of alanine aminotransferase and cardiometabolic risk factors, but not body mass index. Based on gene expression analysis, borderline and definite NASH were associated with abnormal immune function, intestinal cholesterol absorption, and lipid metabolism.

1 January 2014 in The Journal of Pediatrics
Verified
Journal Article
Closed access
SXStavra A. Xanthakos
Stavra A. Xanthakos
DPDaniel J. Podberesky
Daniel J. Podberesky
SSSuraj D. Serai
Suraj D. Serai
LMLili Miles
Lili Miles
EKEileen C. King
Eileen C. King
RKRohit Kohli
Rohit Kohli

23 July 2020 in Gastroenterology
Verified
Journal Article
Closed access
SXStavra A. Xanthakos
Stavra A. Xanthakos
Joel Edward LavineJoel Edward Lavine
Joel Edward Lavine
KYKatherine P. Yates
Katherine P. Yates
JSJeffrey B. Schwimmer
Jeffrey B. Schwimmer
JMJean P. Molleston
Jean P. Molleston
GYGoro Yamada
Goro Yamada